Health News

CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) today introduced Allia™ Celeo,* a ceiling-mounted image guiding system, at the Transcatheter Cardiovascular Therapeutics (TCT) 2026 conference in San Diego. Developed around the principle of smooth procedural flow and built for interventional suites that prioritize high patient throughput and versatility across many indications, Allia Celeo pairs an extra-wide-bore C-arm with intuitive user interface, an AI-powered image chain, and compatib...

SAN CLEMENTE, Calif.--(BUSINESS WIRE)--Reflow Medical, Inc., a leading developer of innovative devices for treating complex cardiovascular disease, announces the presentation of one-year clinical results from the first-in-human DEEPER CORONARY study at Transcatheter Cardiovascular Therapeutics (TCT) 2026, the annual scientific symposium of the Cardiovascular Research Foundation (CRF), in San Diego. The study evaluates the investigational coronary Spur® Elute Sirolimus-Eluting Retrievable Stent...

SAN DIEGO--(BUSINESS WIRE)--Johnson & Johnson announced results from three clinical analyses being presented during the Transcatheter Cardiovascular Therapeutics annual scientific symposium (TCT 2026) that report positive survival and patient outcomes data when Impella™ heart pumps are used to support a patient’s heart during and after high-risk percutaneous coronary intervention (HRPCI). Real-world and observational registry data from 1,379 HRPCI patients across hospitals in the U.S. and E...

BERKELEY, Calif.--(BUSINESS WIRE)--Once Upon a Farm, PBC (NYSE: OFRM) (the “Company”), a leading high-growth company driving systemic improvement in childhood nutrition, today announced that John Foraker, CEO and Co-Founder, will host a business update conference call and webcast on Monday, November 2, 2026, at 8:30 a.m. ET to discuss the Company’s voluntary recall issued on October 30, 2026. To participate in the live call, listeners in the U.S. may dial (877) 269-7751 and international listen...

REDWOOD CITY, Calif.--(BUSINESS WIRE)--Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology company discovering and developing allogeneic gamma delta CAR-T cell and in vivo CAR T therapies for autoimmune diseases, hematologic malignancies and solid tumors, today announced it granted an inducement award on October 30, 2026. One individual was hired by Adicet in October 2026 and granted new hire non-qualified stock options to purchase 1,500 shares of Adicet’s common stock with an exerc...

WASHINGTON--(BUSINESS WIRE)--AHF Hails Introduction of Protect 340B Act of 2026...

RICHMOND, Va.--(BUSINESS WIRE)--Accendra Health, Inc. (NYSE: ACH) (the Company) today announced that on October 27, 2026, it received a notice (the “Notice”) from the New York Stock Exchange (the “NYSE”) notifying the Company that it is not in compliance with Section 802.01B of the NYSE’s continued listing standards that the Company have an average market capitalization of not less than $50.0 million over a consecutive 30 trading-day period and stockholders’ equity of not less than $50.0 millio...

COIMBATORE, India--(BUSINESS WIRE)--Dr. Suthanthiran, founder of Best Medical International, seeks urgent assistance from Indian government officials and relevant authorities to secure the release of advanced cancer treatment technology held in Indian Customs for more than 18 months. The equipment is intended for a proposed nonprofit cancer-treatment center in Coimbatore, Tamil Nadu, where it could help expand access to advanced radiation therapy for patients who cannot afford expensive cancer...

SAN DIEGO--(BUSINESS WIRE)--Avenzo Therapeutics to Present Preliminary Phase 1 Results from ORION-1 Study of AVZO-023, a Selective CDK4 Inhibitor, at the 2026 SABCS...

WALTHAM, Mass.--(BUSINESS WIRE)--The Board of Directors of Revvity, Inc. (NYSE: RVTY), today declared a regular quarterly dividend of $0.07 per share of common stock. This dividend is payable on February 12, 2027 to all shareholders of record at the close of business on January 22, 2027. About Revvity At Revvity, “impossible” is inspiration, and “can’t be done” is a call to action. Revvity provides health science solutions, technologies, expertise and services that deliver complete workflows fr...